| Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation C Chavey, B Mari, MN Monthouel, S Bonnafous, P Anglard, ... Journal of Biological Chemistry 278 (14), 11888-11896, 2003 | 516 | 2003 |
| Metformin inhibits melanoma development through autophagy and apoptosis mechanisms T Tomic, T Botton, M Cerezo, G Robert, F Luciano, A Puissant, P Gounon, ... Cell death & disease 2 (9), e199-e199, 2011 | 342 | 2011 |
| Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product M Deckert, S Tartare-Deckert, C Couture, T Mustelin, A Altman Immunity 5 (6), 591-604, 1996 | 334 | 1996 |
| Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner M Cerezo, M Tichet, P Abbe, M Ohanna, A Lehraiki, F Rouaud, M Allegra, ... Molecular cancer therapeutics 12 (8), 1605-1615, 2013 | 264* | 2013 |
| The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion N Fenouille, M Tichet, M Dufies, A Pottier, A Mogha, JK Soo, S Rocchi, ... PloS one 7 (7), e40378, 2012 | 242 | 2012 |
| Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591–786 (∗) D Sawka-Verhelle, S Tartare-Deckert, MF White, E Van Obberghen Journal of Biological Chemistry 271 (11), 5980-5983, 1996 | 226 | 1996 |
| LIF mediates proinvasive activation of stromal fibroblasts in cancer J Albrengues, I Bourget, C Pons, V Butet, P Hofman, S Tartare-Deckert, ... Cell reports 7 (5), 1664-1678, 2014 | 201 | 2014 |
| Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells Y Cheli, S Giuliano, N Fenouille, M Allegra, V Hofman, P Hofman, ... Oncogene 31 (19), 2461-2470, 2012 | 201 | 2012 |
| SPARC represses E-cadherin and induces mesenchymal transition during melanoma development G Robert, C Gaggioli, O Bailet, C Chavey, P Abbe, E Aberdam, E Sabatié, ... Cancer research 66 (15), 7516-7523, 2006 | 195 | 2006 |
| Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis M Tichet, V Prod’Homme, N Fenouille, D Ambrosetti, A Mallavialle, ... Nature communications 6 (1), 6993, 2015 | 185 | 2015 |
| Surfing the insulin signaling web E Van Obberghen, V Baron, L Delahaye, B Emanuelli, N Filippa, ... European Journal of Clinical Investigation 31 (11), 966-977, 2001 | 170 | 2001 |
| The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression AD Baudot, PY Jeandel, X Mouska, U Maurer, S Tartare-Deckert, ... Oncogene 28 (37), 3261-3273, 2009 | 153 | 2009 |
| Evidence for a Differential Interaction of SHC and the Insulin Receptor Substrate-1 (IRS-1) with the Insulin-like Growth Factor-I (IGF-I) Receptor in the Yeast Two-hybrid … S Tartare-Deckert, D Sawka-Verhelle, J Murdaca, E Van Obberghen Journal of Biological Chemistry 270 (40), 23456-23460, 1995 | 138 | 1995 |
| Adaptor Function for the Syk Kinases–Interacting Protein 3BP2 in IL-2 Gene Activation M Deckert, S Tartare-Deckert, J Hernandez, R Rottapel, A Altman Immunity 9 (5), 595-605, 1998 | 126 | 1998 |
| Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro H Asahara, S Tartare-Deckert, T Nakagawa, T Ikehara, F Hirose, T Hunter, ... Molecular and cellular biology 22 (9), 2974-2983, 2002 | 117 | 2002 |
| The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity S Tartare-Deckert, C Chavey, MN Monthouel, N Gautier, ... Journal of Biological Chemistry 276 (25), 22231-22237, 2001 | 115 | 2001 |
| Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1 C Imbert, A Montfort, M Fraisse, E Marcheteau, J Gilhodes, E Martin, ... Nature communications 11 (1), 437, 2020 | 105 | 2020 |
| PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes L Larribere, M Khaled, S Tartare-Deckert, R Busca, F Luciano, K Bille, ... Cell Death & Differentiation 11 (10), 1084-1091, 2004 | 102 | 2004 |
| HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1 C Gaggioli, M Deckert, G Robert, P Abbe, M Batoz, MU Ehrengruber, ... Oncogene 24 (8), 1423-1433, 2005 | 98 | 2005 |
| Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest O Bailet, N Fenouille, P Abbe, G Robert, S Rocchi, N Gonthier, ... Cancer research 69 (7), 2748-2756, 2009 | 91 | 2009 |
